Summary of Significant Accounting Policies - Revenues by Major Products (Details) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Jun. 30, 2018
USD ($)
product_line
|
Jun. 30, 2017
USD ($)
|
Jun. 30, 2016
USD ($)
|
|
Revenue from External Customer [Line Items] | |||
Number of product lines | product_line | 2 | ||
Revenues | $ 203,204 | $ 199,489 | $ 206,540 |
Revenues percentage | 100.00% | 100.00% | 100.00% |
Product Concentration Risk | Sale Revenues, Gross | |||
Revenue from External Customer [Line Items] | |||
Concentration risk, percentage | 76.60% | 77.90% | 77.90% |
Protandim® product line | |||
Revenue from External Customer [Line Items] | |||
Revenues | $ 133,923 | $ 130,873 | $ 128,019 |
Revenues percentage | 65.90% | 65.60% | 62.00% |
TrueScience® product line | |||
Revenue from External Customer [Line Items] | |||
Revenues | $ 21,665 | $ 24,440 | $ 32,914 |
Revenues percentage | 10.70% | 12.30% | 15.90% |
Other | |||
Revenue from External Customer [Line Items] | |||
Revenues | $ 47,616 | $ 44,176 | $ 45,607 |
Revenues percentage | 23.40% | 22.10% | 22.10% |